Cyclic Di-Nucleotide Compound Useful For The Treatment of Cancer

PK144832APending Publication Date: 2026-07-09EISAI R&D MANAGEMENT CO LTD
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
EISAI R&D MANAGEMENT CO LTD
Filing Date
2018-02-16
Publication Date
2026-07-09
Patent Text Reader

Abstract

Provided herein is a cyclic di-nucleotide compound which can be used for the treatment of cancer. In particular, provided herein is a compound of Formula (III):
Need to check novelty before this filing date? Find Prior Art